Background/Aims: The natural history of thyroid function in children with Down's syndrome is relatively unknown. We hypothesized that in these patients the occurrence of thyroid dysfunction rises during development. Methods: Thyroid function was assessed yearly in 145 children with Down's syndrome, all followed from birth up to 10 years of age. Heteroskedastic binary and ordinary logistic regression for repeated measures was used to evaluate the relationship of thyroid function with continuous time. Results: Congenital hypothyroidism was detected in 7% of cases. The probability of acquired thyroid dysfunction increased from 30% at birth to 49% at 10 years (p < 0.001). The subclinical hypothyroidism was nearly stable during the follow-up. The probability of hypothyroidism increased from 7 to 24% at 10 years (p < 0.001). Positive anti-thyroglobulin antibodies were associated with higher odds of more severe hypothyroidism (odds ratio 3.6). Positive anti-thyroid peroxidase antibodies were a better predictor of more severe hypothyroidism (odds ratio 6.1). Diffuse hypoechogenicity on thyroid ultrasound was found in 34 out of 145 children. Conclusion: The probability of thyroid dysfunction increasing during development is higher than previously reported. Such children should be carefully monitored annually to early identify thyroid dysfunction.

Keywords:
Thyroid function, Thyroid autoantibodies, Natural history, Down’s syndrome, Children
1.
Radetti G, Drei F, Betterle C, Mengarda G: Down's syndrome, hypothyroidism and insulin-dependent diabetes mellitus. Helv Paediatr Acta 1986;41:377-380.
2.
Prasher VP: Down syndrome and thyroid disorders: a review. Downs Syndr Res Pract 1999;6:25-42.
3.
Weijerman ME, de Winter JP: Clinical practice. The care of children with Down syndrome. Eur J Pediatr 2010;169:1445-1452.
4.
Pueschel SM, Jackson IM, Giesswein P, Dean MK, Pezzullo JC: Thyroid function in Down syndrome. Res Dev Disabil 1991;12:287-296.
5.
Gibson PA, Newton RW, Selby K, Price DA, Leyland K, Addison GM: Longitudinal study of thyroid function in Down's syndrome in the first two decades. Arch Dis Child 2005;90:574-578.
6.
Murphy J, Philip M, Macken S, Meehan J, Roche E, Mayne PD, O'Regan M, Hoey HM: Thyroid dysfunction in Down's syndrome and screening for hypothyroidism in children and adolescents using capillary TSH measurement. J Pediatr Endocrinol Metab 2008;21:155-163.
7.
Regueras L, Prieto P, Muñoz-Calvo MT, Pozo J, Arguinzoniz L, Argente J: Endocrinological abnormalities in 1,105 children and adolescents with Down syndrome. Med Clin (Barc) 2011;136:376-381.
8.
McGowan S, Jones J, Brown A, Reynolds L, Leyland K, Charleton P, Rahim M, Mansor M, Ritha S, Donaldson M, Scottish Down Syndrome Thyroid Screening Group: Capillary TSH screening programme for Down's syndrome in Scotland, 1997-2009. Arch Dis Child 2011;96:1113-1117.
9.
Kishnani PS, Crissman BG: Special issue: current perspectives on Down syndrome: selected medical and social issues. Am J Med Genet C Semin Med Genet 2006;142C:127-205.
10.
Unachak K, Tanpaiboon P, Pongprot Y, Sittivangkul R, Silvilairat S, Dejkhamron P, Sudasna J: Thyroid functions in children with Down's syndrome. J Med Assoc Thai 2008;91:56-61.
11.
Fort P, Lifshitz F, Bellisario R, Davis J, Lanes R, Pugliese M, Richman R, Post EM, David R: Abnormalities of thyroid function in infants with Down syndrome. J Pediatr 1984;104:545-549.
12.
Cutler AT, Benezra-Obeiter R, Brink SJ: Thyroid function in young children with Down syndrome. Am J Dis Child 1986;140:479-483.
13.
Jaruratanasirikul S, Patarakijvanich N, Patanapisarnsak C: The association of congenital hypothyroidism and congenital gastrointestinal anomalies in Down's syndrome infants. J Pediatr Endocrinol Metab 1998;11:241-246.
14.
Tüysüz B, Beker DB: Thyroid dysfunction in children with Down's syndrome. Acta Paediatr 2001;90:1389-1393.
15.
Shaw CK, Thapalial A, Nanda S, Shaw P: Thyroid dysfunction in Down syndrome. Kathmandu Univ Med J 2006;4:182-186.
16.
Karlsson B, Gustafsson J, Hedov G, Ivarsson SA, Annerén G: Thyroid dysfunction in Down's syndrome: relation to age and thyroid autoimmunity. Arch Dis Child 1998;79:242-245.
17.
Rubello D, Pozzan GB, Casara D, Girelli ME, Boccato S, Rigon F, Baccichetti C, Piccolo M, Betterle C, Busnardo B: Natural course of subclinical hypothyroidism in Down's syndrome: prospective study results and therapeutic considerations. J Endocrinol Invest 1995;18:35-40.
18.
Goday-Arno A, Cerda-Esteva M, Flores-Le-Roux JA, Chillaron-Jordan JJ, Corretger JM, Cano-Pérez JF: Hyperthyroidism in a population with Down syndrome. Clin Endocrinol (Oxf) 2009;71:110-114.
19.
Radetti G, Gottardi E, Bona G, Corrias A, Salardi S, Loche S, Study Group for Thyroid Diseases of the Italian Society for Pediatric Endocrinology and Diabetes (SIEDP/ISPED): The natural history of euthyroid Hashimoto's thyroiditis in children. J Pediatr 2006;149:827-832.
20.
Radetti G, Maselli M, Buzi F, Corrias A, Mussa A, Cambiaso P, Salerno M, Cappa M, Baiocchi M, Gastaldi R, Minerba L, Loche S: The natural history of the normal/mild elevated TSH serum levels in children and adolescents with Hashimoto's thyroiditis and isolated hyperthyrotropinaemia: a 3-year follow-up. Clin Endocrinol (Oxf) 2012;76:394-398.
21.
Monzani A, Prodam F, Rapa A, Moia S, Agarla V, Bellone S, Bona G: Natural history of subclinical hypothyroidism in children and adolescents and potential effects of replacement therapy: a review. Eur J Endocrinol 2012;168:R1-R11.
22.
Myrelid A, Jonsson B, Guthenberg C, von Döbeln U, Annerén G, Gustafsson J: Increased neonatal thyrotropin in Down syndrome. Acta Paediatr 2009;98:1010-1013.
23.
Elfström P, Montgomery SM, Kämpe O, Ekbom A, Ludvigsson JF: Risk of thyroid disease in individuals with celiac disease. J Clin Endocrinol Metab 2008;93:3915-3921.
24.
Kim SH, Chung HR, Kim SH, Kim H, Lim BC, Chae JH, Kim KJ, Hwang YS, Hwang H: Subclinical hypothyroidism during valproic acid therapy in children and adolescents with epilepsy. Neuropediatrics 2012;43:135-139.
25.
Van Santen HM, Thonissen NM, de Kraker J, Vulsma T: Changes in thyroid hormone state in children receiving chemotherapy. Clin Endocrinol (Oxf) 2005;62:250-257.
26.
Hilbe JM: Generalized Linear Models and Extensions. College Station/TX, Stata Press, 2012.
27.
Williams R: Fitting heterogeneous choice models with OGLM. Stata J 2010;10:540-567.
28.
Loudon MM, Day RE, Duke EM: Thyroid dysfunction in Down's syndrome. Arch Dis Child 1985;60:1149-1151.
29.
Prasher V, Ninan S, Haque S: Fifteen-year follow-up of thyroid status in adults with Down syndrome. J Intellect Disabil Res 2011;55:392-396.
30.
Van Trotsenburg ASP, Vulsma T, van Santen HM, Cheung W, de Vijlder JJM: Lower neonatal screening thyroxine concentrations in Down syndrome newborns. J Clin Endocrinol Metab 2003;88:1512-1515.
31.
Deladoëy J, Ruel J, Giguère Y, Van Vliet G: Is the incidence of congenital hypothyroidism really increasing? A 20-year retrospective population-based study in Québec. J Clin Endocrinol Metab 2011;96:2422-2429.
32.
Sharav T, Collins R, Baab P: Growth studies in infants and children with Down's syndrome and elevated levels of thyrotropin. Am J Dis Child 1988;142:1302-1306.
33.
Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, Franklyn JA, Hershman JM, Burman KD, Denke MA, Gorman C, Cooper RS, Weissman NJ: Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004;291:228-238.
34.
Lazar L, Frumkin RB, Battat E, Lebenthal Y, Phillip M, Meyerovitch J: Natural history of thyroid function tests over 5 years in a large pediatric cohort. Endocrinol Metab 2009;94:1678-1682.
35.
Zois C, Stavrou I, Svarna E, Seferiadis K, Tsatsoulis A: Natural course of autoimmune thyroiditis after elimination of iodine deficiency in northwestern Greece. Thyroid 2006;16:289-293.
36.
Meyerovitch J, Antebi F, Greenberg-Dotan S, Bar-Tal O, Hochberg Z: Hyperthyrotropinaemia in untreated subjects with Down's syndrome aged 6 months to 64 years: a comparative analysis. Arch Dis Child 2012;97:595-598.
37.
Selikowitz M: A five-year longitudinal study of thyroid function in children with Down syndrome. Dev Med Child Neurol 1993;35:396-401.
38.
Faria CD, Ribeiro S, Kochi C, Silva AP, Ribeiro BN, Marçal LT, Santos FH, Eduardo CP, Monte O, Longui CA: TSH neurosecretory dysfunction in Down syndrome: low risk of progression to Hashimoto's thyroiditis. Arq Bras Endocrinol Metabol 2011;55:628-631.
39.
Ivarsson SA, Ericsson UB, Gustafsson J, Forslund M, Vegfors P, Annerén G: The impact of thyroid autoimmunity in children and adolescents with Down syndrome. Acta Paediatr 1997;86:1065-1067.
40.
Dias VM, Nunes JC, Araújo SS, Goulart EM: Etiological assessment of hyperthyrotropinemia in children with Down's syndrome. J Pediatr (Rio J) 2005;81:79-84.
41.
Freeman SB, Torfs CA, Romitti MH, Royle MH, Druschel C, Hobbs CA, Sherman SL: Congenital gastrointestinal defects in Down syndrome: a report from the Atlanta and National Down Syndrome Projects. Clin Genet 2009;75:180-184.
42.
Cappa M, Bizzarri C, Crea F: Autoimmune thyroid diseases in children. J Thyroid Res 2011;2011:675-703.
43.
Van Trotsenburg AS, Kempers MJ, Endert E, Tijssen JG, de Vijlder JJ, Vulsma T: Trisomy 21 causes persistent congenital hypothyroidism presumably of thyroidal origin. Thyroid 2006;16:671-680.
44.
Roberts CGP, Ladenson PW: Hypothyroidism. Lancet 2004;363:793-803.
45.
Popova G, Paterson WF, Brown A, Donaldson MD: Hashimoto's thyroiditis in Down's syndrome: clinical presentation and evolution. Horm Res 2008;70:278-284.
46.
Van Trotsenburg ASP, Vulsma T, van Rozenburg-Marres SL, van Baar AL, Ridder JC, Heymans HS, Tijssen JG, de Vijlder JJ: The effect of thyroxine treatment started in the neonatal period on development and growth of two-year-old Down syndrome children: a randomized clinical trial. J Clin Endocrinol Metab 2005;90:3304-3311.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.